
Sign up to save your podcasts
Or


On Health Suites, AstraZeneca has signed a new purchase agreement with the government of Singapore to deliver Evusheld, its long-acting antibody (LAAB) combination candidate, for the treatment of COVID-19. With the supply expected to arrive in Singapore by year end, Claressa Monteiro speaks to Vinod Narayanan, Country President, AstraZeneca Singapore, to find out more about Evusheld.
See omnystudio.com/listener for privacy information.
By MONEY FM 89.3On Health Suites, AstraZeneca has signed a new purchase agreement with the government of Singapore to deliver Evusheld, its long-acting antibody (LAAB) combination candidate, for the treatment of COVID-19. With the supply expected to arrive in Singapore by year end, Claressa Monteiro speaks to Vinod Narayanan, Country President, AstraZeneca Singapore, to find out more about Evusheld.
See omnystudio.com/listener for privacy information.

3,217 Listeners

970 Listeners

1 Listeners

17 Listeners

1,302 Listeners

0 Listeners

0 Listeners

1 Listeners

6 Listeners

80 Listeners

2 Listeners

1 Listeners

3 Listeners

23 Listeners

139 Listeners